Cereblon (CRBN) gene polymorphisms predict clinical response and progression-free survival in relapsed/refractory multiple myeloma patients treated with lenalidomide: a pharmacogenetic study from the IMMEnSE consortium
| Image |  |
|---|---|
| Description | scientific article published on 20 November 2019 |
| Author/s |
author: Edyta Subocz Małgorzata Krawczyk-Kulis Małgorzata Razny Daria Zawirska Artur Jurczyszyn Marzena Wątek Norbert Grzasko Aleksandra Butrym Waldemar Tomczak Federico Canzian Grzegorz Mazur Krzysztof Jamroziak Marcin Kruszewski Elżbieta Iskierka-Jażdżewska Jan Maciej Zaucha Marcin Pasiarski Krzysztof Warzocha Tadeusz Robak Slawomira Kyrcz-Krzemien Malgorzata Calbecka Jan Walewski Agnieszka Druzd-Sitek Pawel Gaj |
| Publication date | November 20, 2019 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |